David Dodds

Presidente presso Sucampo Pharma Europe Ltd.

Commercial Services

Consumer Services

Profilo

David Dodds has been Commercial Director of Sucampo Pharma Europe Ltd.
since August 7, 2008.
Mr. Dodds had been Senior International Marketing Manager for Pharmion Ltd since July 2005.
Prior to Pharmion, he held various sales and marketing positions, with Mitsubishi Pharma Europe Ltd., Yamanouchi Pharmaceuticals Europe BV, SmithKline Beecham, Eli Lilly and ICI Pharmaceuticals.
Mr. Dodds has experience in developing and managing business development activities with prospective in-licensees and partners.
He received his Executive MBA from The Open Business School and an Honours degree in Pharmacy from the University of Sunderland School of Pharmacy.

Posizioni attive di David Dodds

Società	Posizione	Inizio
Sucampo Pharma Europe Ltd. Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006.	Presidente	15/09/2009

Tutte le posizioni attive di David Dodds

Formazione di David Dodds

University of Sunderland

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David Dodds

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Sucampo Pharma Europe Ltd. Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006.	Commercial Services